Inventor · disambiguated record
David B. Ring
Also filed as: RING DAVID · RING DAVID B · RING DAVID BARRATT
33 granted patents·5 pending applications·2,932 citations·filing 1984–2006
98Inventor score
Files withCHIRON CORP22CETUS CORP8CETUS ONCOLOGY CORP1CREATIVE BIOMOLECULES INC1DANA FARBER CANCER INST INC1
Top patents by PatentIndex Score
38 records- 0198US6054561AAntigen-binding sites of antibody molecules specific for cancer antigensCHIRON CORP·Filed 1995·Granted Apr 25, 2000·362 cites·31 claims
- 0298US5877305ADNA encoding biosynthetic binding protein for cancer markerCHIRON CORP·Filed 1994·Granted Mar 2, 1999·285 cites·3 claims
- 0398US5534254ABiosynthetic binding proteins for immuno-targetingCHIRON CORP·Filed 1993·Granted Jul 9, 1996·288 cites·30 claims
- 0498US4938948AMethod for imaging breast tumors using labeled monoclonal anti-human breast cancer antibodiesCETUS CORP·Filed 1985·Granted Jul 3, 1990·212 cites·9 claims
- 0598US4753894AMonoclonal anti-human breast cancer antibodiesCETUS CORP·Filed 1985·Granted Jun 28, 1988·459 cites·29 claims
- 0697US5169774AMonoclonal anti-human breast cancer antibodiesCETUS ONCOLOGY CORP·Filed 1988·Granted Dec 8, 1992·148 cites·4 claims
- 0795US7425557B2Inhibitors of glycogen synthase kinase 3NOVARTIS VACCINES & DIAGNOSTIC·Filed 2005·Granted Sep 16, 2008·19 cites·24 claims
- 0894US7045519B2Inhibitors of glycogen synthase kinase 3CHIRON CORP·Filed 2001·Granted May 16, 2006·46 cites·44 claims
- 0994US6417185B1Inhibitors of glycogen synthase kinase 3CHIRON CORP·Filed 1999·Granted Jul 9, 2002·108 cites·13 claims
- 1093US7037918B2Inhibitors of glycogen synthase kinase 3CHIRON CORP·Filed 2002·Granted May 2, 2006·49 cites·3 claims
- 1192US6153618AInhibitors of glycogen synthase 3 kinaseCHIRON CORP·Filed 1997·Granted Nov 28, 2000·56 cites·26 claims
- 1292US6106833ABispecific antibodies, methods of production and use thereofCHIRON CORP·Filed 1997·Granted Aug 22, 2000·115 cites·10 claims
- 1392US5629197AMonoclonal anti-human breast cancer antibodiesCHIRON CORP·Filed 1994·Granted May 13, 1997·93 cites·6 claims
- 1490US6489344B1Inhibitors of glycogen synthase kinase 3CHIRON CORP·Filed 1999·Granted Dec 3, 2002·76 cites·34 claims
- 1590US6057117AIdentification and use of selective inhibitors of glycogen synthase kinase 3CHIRON CORP·Filed 1999·Granted May 2, 2000·100 cites·11 claims
- 1690US5959084ABispecific antibodies, methods of production and uses thereofCHIRON CORP·Filed 1995·Granted Sep 28, 1999·165 cites·9 claims
- 1788US6479284B1Humanized antibody and uses thereofDANA FARBER CANCER INST INC·Filed 2000·Granted Nov 12, 2002·74 cites·32 claims
- 1881US5837846ABiosynthetic binding proteins for immuno-targetingCREATIVE BIOMOLECULES INC·Filed 1995·Granted Nov 17, 1998·25 cites·12 claims
- 1981US4956453AAnti-human ovarian cancer immunotoxins and methods of use thereofCETUS CORP·Filed 1987·Granted Sep 11, 1990·47 cites·27 claims
- 2080US7138497B2Biosynthetic binding proteins for immuno-targetingCHIRON CORP·Filed 2001·Granted Nov 21, 2006·8 cites·2 claims
- 2180US4958009AAnti-human ovarian cancer immunotoxins and methods of use thereofCETUS CORP·Filed 1987·Granted Sep 18, 1990·46 cites·19 claims
- 2279US5753204ABiosynthetic binding proteins for immunotargetingCHIRON CORP·Filed 1995·Granted May 19, 1998·22 cites·21 claims
- 2379US4727037AAssay kit and method for the determination of antibody class and subclassCETUS CORP·Filed 1984·Granted Feb 23, 1988·33 cites·15 claims
- 2466US5705614AMethods of producing antigen forksCHIRON CORP·Filed 1995·Granted Jan 6, 1998·29 cites·1 claims
- 2565US7053097B1Inhibitors of glycogen synthase 3 kinaseCHIRON CORP·Filed 2000·Granted May 30, 2006·2 cites·10 claims
- 2662US2006147444A1Biosynthetic binding proteins for immuno-targetingHUSTON JAMES S·Filed 2003·Application pending·0 cites
- 2761US5849877AAntigen-binding sites of antibody molecules specific for cancer antigensCHIRON CORP·Filed 1995·Granted Dec 15, 1998·11 cites·9 claims
- 2860US5948647ANucleic acids encoding antigen-binding sites specific for cancer antigensCHIRON CORP·Filed 1995·Granted Sep 7, 1999·10 cites·26 claims
- 2960US4569915AP. obtusus strainCETUS CORP·Filed 1984·Granted Feb 11, 1986·6 cites·4 claims
- 3059US4803169AAssay for human breast cancerCETUS CORP·Filed 1986·Granted Feb 7, 1989·19 cites·11 claims
- 3156US5811267AIsolated nucleic acid molecules encoding antigen binding sites of antibody molecules specific for cancer antigensCHIRON CORP·Filed 1995·Granted Sep 22, 1998·8 cites·11 claims
- 3254US2006177454A1Method of promoting an immune response with a bispecific antibodyRING DAVID B·Filed 2006·Application pending·0 cites
- 3347US2007031931A1Biosynthetic binding proteins for immuno-targetingCHIRON CORP·Filed 2006·Application pending·0 cites
- 3441US6143873AMonoclonal anti-multiple drug resistance antibody, methods of production and uses thereofCHIRON CORP·Filed 1999·Granted Nov 7, 2000·3 cites·3 claims
- 3541US5725850AUse of CSF-1 to treat tumor burdenCHIRON CORP·Filed 1995·Granted Mar 10, 1998·5 cites·14 claims
- 3638US2002041865A1Methods for treating tumorsFiled 2001·Application pending·0 cites
- 3734US4568645AFungal pyranose-2-oxidase preparationsCETUS CORP·Filed 1984·Granted Feb 4, 1986·3 cites·6 claims
- 3831US2003086922A1Method of promoting an immune response with a bispecific antibodyFiled 1994·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David B. Ring files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →